what we offer

Comprehensive commercialization solutions

We are proactive and transparent in providing optimal solutions across all commercialization phases​

Guiding you to effective market entry

Maximizing market access for early patient treatment

Our focus is providing the most effective market access strategies for each country, covering all stages from Medical Affairs to final distribution. We leverage FDA / EMA approvals to ensure patients get early access to treatment through named patient programs (NPP).

A ‘’One-Stop Shop’’ model across 30+ countries

Simplify your operations with our single point of contact, streamlining due diligence, audits, language, currency, and adherence to European GDP and GMP standards.

Adapting to global changes by tailored regulatory solutions

Our capability includes delivering highly tailored responses to meet the unique regulatory requirements of each country and product. We promptly adapt to changes and mitigate risks in the evolving regulatory environment.

High level of dedication​

Clear communication and innovative solutions

Our deep expertise ensures transparent interactions, providing creative and effective solutions tailored to your requirements.

Tailored forecast and timeline for your product

We will make an advanced analysis that includes forecasts of market size, along with a customized timeline for your product's specific needs.

Market access pathway timeline

Kick-off meeting

Introducing the project and finalizing the agreement.

in 0-3 MONTHS

Assessment

We evaluate market dynamics and competition to understand the landscape.

In 3-9 MONTHS

Identification of market access pathways

Determine access pathways based on known NPPs, EAPs, and local laws for rare disease products.

in 9-15 MONTHS

identification of KOLs and CoEs

We provide key opinion leaders and centers of excellence to support the project.

FDA APPROVAL

Launch

Achieving regulatory approval necessary for launching the product.

We can launch and access patients already here​

In Biomedica countries.

in 0-6 months

Monitoring

To ensure product performance and patient safety.

Did you know that 10% of the global population is affected by
rare diseases?

Explore Our Rare Disease Expertise

Looking for a strategic guidance?

Reach out to our team for market assessment specific to your product and understand the financial impact you can achieve by partnering with us.

We use cookies on our website to improve your experience and analyze traffic. By clicking "Accept" you consent to our use of cookies. See Privacy Policy